EP1095256A2 - Cytometre en flux a ouverture numerique elevee et procede de son utilisation - Google Patents

Cytometre en flux a ouverture numerique elevee et procede de son utilisation

Info

Publication number
EP1095256A2
EP1095256A2 EP00914609A EP00914609A EP1095256A2 EP 1095256 A2 EP1095256 A2 EP 1095256A2 EP 00914609 A EP00914609 A EP 00914609A EP 00914609 A EP00914609 A EP 00914609A EP 1095256 A2 EP1095256 A2 EP 1095256A2
Authority
EP
European Patent Office
Prior art keywords
light
scattered
light detector
laser
flow cytometer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP00914609A
Other languages
German (de)
English (en)
Inventor
Anthony A. Ferrante
W. Peter Hansen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Idexx Laboratories Inc
Original Assignee
Idexx Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idexx Laboratories Inc filed Critical Idexx Laboratories Inc
Publication of EP1095256A2 publication Critical patent/EP1095256A2/fr
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Optical investigation techniques, e.g. flow cytometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/01—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
    • G01N2015/016—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Optical investigation techniques, e.g. flow cytometry
    • G01N15/1434—Optical arrangements
    • G01N2015/1447—Spatial selection

Definitions

  • the present invention relates to particle discrimination by light scattering, and more particularly to a flow cytometer and method therefore that discriminates particles employing a high numerical aperture.
  • Numerical aperture is defined as the refractive index of the medium through which light is collected multiplied by the sine value of one- half of the angle of light collection.
  • the discrimination of particles is useful in numerous clinical assays including ascertaining the types and numerical quantity of cells in blood, ascertaining invasive particles in a fluid sample, such as bacteria and virus, and quantifying the density and volume of cells in a fluid sample.
  • the '497 Patent discloses a flow cell 2 through which cells from, for example, blood or the like, flow substantially one by one therethrough.
  • a laser input 4 emits a polarized beam of laser light that is oriented substantially orthogonally to the flow of blood cell through flow cell 2 such that the polarized laser light impinges upon the blood cells as they pass through flow cell 2.
  • polarized it is meant that the plane of the electric field oscillization of the laser light is uniform.
  • An optical lens 6 has an aperture which limits the cone of scattered light from the blood cells that can be collected to 72° or less. The central axis of the cone of lens 6 is 90° to both the path of the polarized laser light and the flow of blood cells through flow cell 2.
  • the scattered light emulating from lens 6 is columnated in a matter known in the art.
  • the scattered light now has a mixed polarization that is characteristic of the cell type.
  • the light next passes through a beam splitter 8 that divides the light into two separate beams.
  • a first light beam, substantially concentric with the light beam that originally eminated from lens 6, passes through first polarization analyzer 10.
  • Polarization analyzer 10 is configured to pass therethrough only polarized light having a vector the same as the original laser light.
  • the second beam eminating from beam splitter 8 is oriented substantially perpendicular to the orientation of the first beam eminating from beam splitter 8. This second beam enters second polarization analyzer 12.
  • Second polarization analyzer 12 is configured to pass therethrough only light having a polarization vector substantially orthogonal to the polarization vector of the other beam from beam splitter 8 that passed through first polarization analyzer 10.
  • the beams that pass through first polarization analyzer 10 and second polarization 12 enter polarized detector 14 and depolarized light detector 16, respectively.
  • FIG. 4 is a graphical representation having the output of polarized light detector 14 as one axis and the output of depolarized light detector 16 as the axis. While the above invention does provide some useful data regarding leukocytes, and more specifically eosinophils, as shown in FIGS.
  • the cluster points within the eosinophil cluster are quite condensed.
  • the dense nature of the points within the eosinophil cluster results in difficulty for the computer software programs that ascertain and identify clusters to accurately identify eosinophil clusters.
  • this prior art configuration requires expensive optical devices such as photo multiplier tubes, and lens 6, first polarization amplifier 10 and second polarization amplifier 12.
  • the high numerical aperture flow cytometer of the present invention includes a flow cell and a laser input.
  • the laser input emits a beam of light that is oriented substantially orthoganilly to the flow of blood cells through the flow cell such that laser light impinges upon the blood cells as they pass through the flow cell.
  • the laser light emitted by the laser input need not be polarized for analysis of the cells according to the present invention.
  • a portion of the beam from the laser input that impinges upon the blood cells in the flow cell is scattered at a substantially right angle to the beam of laser input ("right angle scatter light").
  • a second portion of the beam from the laser input that impinges upon the cells in the flow cell is scattered at a much lower angle than 90°.
  • This scatter is termed "low angle forward scatter light” and has an angle of from about 2° to about 5° from the orientation of the original beam from laser input.
  • a right angle scatter light detector is oriented to receive the previously mentioned right angle scatter light.
  • the right angle scatter light detector is preferably located about 2 millimeters from the blood cells in the flow cell.
  • An important aspect of the present invention is that, at the distance of about 2 millimeters from the blood cells, the right angle scatter light detector collects a cone of scattered light of at least 100° or greater, and preferably 130° or greater. It is this larger light cone value over the prior art light cone of about 72° that results in the greater cluster separation in the present invention due to the larger signal gathered. In contrast, the smaller 72° cone of the prior art results in missed signals and lesser cluster separation.
  • a low angle forward scatter light detector is oriented to capture the previously mentioned low angle forward scatter light oriented at about 2° to about 5° from the beam of the laser input.
  • both right angle scatter light detector and low angle forward scatter light detector are employed in order to produce a 2- dimensional cytrogram.
  • only right angle scatter light detector is employed, low angle forward scatter light detector is not employed, and characterization of eosinophils is possible.
  • FIG. 1 is a schematic representation of the electro-optical components of prior art
  • FIG. 2 is a schematic representation of the electro-optical components of the present invention
  • FIG. 3 is a block diagram of the electronic processing components of the present invention.
  • FIG. 4 is a graphical representation of the separation of eosinophils and other white blood cell components based on light scatter in the prior art
  • FIG. 5 is a graphical representation of the separation of eosinophils and other white blood cell components based on light scatter in the present invention
  • FIG. 6 A is a graphical representation of 2% canine eosinophil data employing the prior art
  • FIG. 6B is a graphical representation of 2% canine eosinophil data employing the present invention.
  • FIG. 7A is a graphical representation of 8% canine eosinophil data employing the prior art
  • FIG. 7B is a graphical representation of 8% canine eosinophil data employing the present invention
  • FIG. 8 A is a graphical representation of 10% canine eosinophil data employing the 5 prior art
  • FIG. 8B is a graphical representation of 10% canine eosinophil data employing the present invention.
  • FIG. 9 A is a graphical representation of human eosinophil data employing the prior 0 art.
  • FIG. 9B is a graphical representation of human eosinophil data employing the present invention.
  • the high numerical aperture flow cytometer of the present invention includes a flow cell 18, which is preferably a quartz flow cell manufactured by Opco Laboratories of Fitchburg, Massachusetts.
  • flow cell 18 has a flow length of about 1 centimeter and a cross section of 4 millimeter by 4 millimeter. Cells from, for example, blood or the like, flow substantially one by one through flow cell 18 during
  • Laser input 20 emits a beam of light that is oriented substantially orthoganilly to the flow of blood cells through flow cell 18 such that laser light impinges upon the blood cells as they pass through flow cell 18. Unlike the prior art, the laser light emitted by laser input 20 need not be polarized for analysis of the cells according to the present invention. .
  • Laser input 20 maybe for example a 635 manometer semiconductor diode laser with an output power of 10 miliwatts, model No. HL6320G manufactured by Hatachi and available from Thor Labs, Inc. of Newton, New Jersey.
  • a portion of the beam from laser input 20 that impinges upon the blood cells in flow cell 18 is scattered at a substantially right angle to the beam of laser input 20 ("right angle scatter light").
  • right angle scatter light detector 22 is oriented to receive the previously mentioned right angle scatter light.
  • Right angle scatter light detector is preferably located about 2 millimeters from the blood cells in the flow cell 18.
  • An important aspect of the present invention is that, at the distance of about 2 millimeters from the blood cells, right angle scatter light detector 22 collects a cone of scattered light of at least 100° or greater, and preferably 130° or greater. It is this larger light cone value over the prior art light cone of about 72° that results in the greater cluster separation in the present invention due to the larger signal gathered. In contrast, the smaller 72° cone of the prior art results in missed signals and lesser cluster separation.
  • Low angle forward scatter light detector 24 is oriented to capture the previously mentioned low angled forward scatter light oriented at about 2° to about 5° from the beam of laser input 20.
  • Both right angle scatter light detector 22 and low angle forward scatter light detector 24 can be, for example, silicone PIN photodiodes Model No. S5106PIN manufactured by Hamamatsu Corp. of Bridgewater, New Jersey.
  • both right angle scatter light detector 22 and low angle forward scatter light detector 24 are employed in order to produce a 2- dimensional cytrogram.
  • only right angle scatter light detector 22 is employed, low angle forward scatter light detector 24 is not employed, and characterization of eosinophils is possible.
  • the electrical outputs from right angle scatter light detector 22 and low angle forward scatter light detector 24, which may be in voltage or current form, for example, are amplified by preamplifier 26 and then sent to signal processor 28.
  • Signal processor 28 measures the area under the voltage or current curve, or measures the peak of the voltage or current curve, received from right angle light scatter detector 22 and/or low 5 angle forward scatter light detector 24.
  • the data from signal processor 28 is converted by analog to digital converter 30.
  • the digital data is next processed by central processing unit 32 based on software programs to display the data in graphical representation on display 34. It will be readily apparent to those skilled in the art that the signal amplification, processing, conversion and display can be accomplished by many well ⁇ o known methods, including but not limited to those disclosed in Practical Flow Cytometry
  • FIG. 5 the output of the data from the flow cytometer of the present invention is shown.
  • FIG. 5 has the output of right angle scatter light detector 22 as one axis and the output of low angle forward scatter light detector 24 as the other axis.
  • Eosinophils are located to the right of the software threshold line and, as shown in FIGS.
  • FIGS. 6A, 6B, 7A, 7A, 7B, 8A, 8B, 9A and 9B graphical representations of leukocyte identification is shown, with specific reference to eosinophil identification.
  • the data of FIGS. 6 A, 7 A, 8 A, and 9 A was employed using the apparatus of the present invention.
  • the term R2 denotes primarily
  • FIGS. 6B, 7B, 8B, and 9B pertain to data employing an apparatus substantially disclosed in US Patent No. 5,017,497.
  • Whole blood samples of either canine or human blood were prepared as follows before analyzing with the apparatus of present invention or the prior art. The whole blood sample was diluted 10 to
  • phosphate buffered saline treated whole blood sample was mixed with 1 ,200 microliters of a lysing solution.
  • the lysing solution consisted of 8.3 grams of ammonium chloride, 1 gram of potassium bicarbonate, 0.37 grams tetrasodium EDTA per liter of lysing solution.
  • the whole blood sample was lysed for 20 minutes to one-half of an hour. It will be readily understood by those skilled in the art that lyse time can readily be reduced to between 30 seconds and one minute.
  • FIGS. 6A, 7A, 8 A and 9 ⁇ A good correlation exists between the eosinophil of the present invention of FIGS. 6A, 7A, 8 A and 9 ⁇ with the eosinophil data of the DEPOL/ORTHOGONAL graphical representation of the prior art as shown in FIGS. 6B, 7B, 8B and 9B. More specifically, regarding FIGS. 6A and 6B, the eosinophil value for the present invention is 2.1% and for the prior art is 2.0%. Regarding FIGS. 7A and 7B, the eosinophil data for the present invention is 7.6% and for the prior art is 8.2%. Regarding FIGS. 8A and 8B the eosinophil data for the present invention is 13.1% and for the prior art is 9.8%. Regarding FIGS.
  • FIGS. 6A, 7 A, 8 A and 9 A an eosinophil cluster is present at R5.
  • the SIZE/COMPLEXITY graphical representation shows no eosinophil cluster, while the graphical representation of FIG. 9B does show a cluster.
  • FIGS. 6A, 7 A, 8 A and 9A show a marked decreased density or concentration of the cluster points within the eosinophil clusters.
  • the separation of these cluster points allows the software programs that locate and identify different clusters to more readily locate and identify the clusters produced by the apparatus and method of the present invention compared to those of the prior art.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Selon cette invention, un cytomètre en flux à ouverture numérique comprend une cuve à circulation et une entrée laser. L'entrée laser émet un faisceau de lumière orienté de façon sensiblement orthogonale par rapport au flux de globules traversant la cuve à circulation, de manière à ce que la lumière laser tombe sur les globules pendant qu'elles traversent la cuve à circulation. Une partie du faisceau provenant de l'entrée laser qui tombe sur les globules dans la cuve à circulation est diffusée sous un angle sensiblement droit par rapport à l'entrée laser ('diffusion à angle droit'). Une deuxième partie du faisceau provenant de l'entrée laser qui tombe sur les cellules dans la cuve à circulation est diffusée sous un angle sensiblement inférieur à 90°. Cette diffusion est appelée 'lumière de diffusion vers l'avant à faible angle d'ouverture', l'angle de diffusion étant compris entre 2° et 5° par rapport à l'orientation du faisceau d'origine provenant de l'entrée laser. Un détecteur de diffusion de lumière sous angle droit est orienté de manière à recevoir la lumière diffusée sous angle droit mentionné plus haut. Un détecteur de lumière diffusée à faible angle d'ouverture est orienté pour capter la lumière diffusée sous un angle à faible ouverture mentionné plus haut, diffusé vers l'avant et orienté avec un angle compris entre 2° et 5° par rapport à l'orientation du faisceau d'origine provenant de l'entrée laser.
EP00914609A 1999-02-19 2000-02-18 Cytometre en flux a ouverture numerique elevee et procede de son utilisation Ceased EP1095256A2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12080499P 1999-02-19 1999-02-19
US120804P 1999-02-19
PCT/US2000/004069 WO2000049387A2 (fr) 1999-02-19 2000-02-18 Cytometre en flux a ouverture numerique elevee et procede de son utilisation

Publications (1)

Publication Number Publication Date
EP1095256A2 true EP1095256A2 (fr) 2001-05-02

Family

ID=22392650

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00914609A Ceased EP1095256A2 (fr) 1999-02-19 2000-02-18 Cytometre en flux a ouverture numerique elevee et procede de son utilisation

Country Status (5)

Country Link
EP (1) EP1095256A2 (fr)
JP (1) JP2002537557A (fr)
AU (1) AU768616C (fr)
CA (1) CA2329031C (fr)
WO (1) WO2000049387A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6149867A (en) 1997-12-31 2000-11-21 Xy, Inc. Sheath fluids and collection systems for sex-specific cytometer sorting of sperm
US6618143B2 (en) * 2000-02-18 2003-09-09 Idexx Laboratories, Inc. High numerical aperture flow cytometer and method of using same
AU2002220018A1 (en) 2000-11-29 2002-06-11 Colorado State University System for in-vitro fertilization with spermatozoa separated into x-chromosome and y-chromosome bearing populations
US7169548B2 (en) 2002-09-13 2007-01-30 Xy, Inc. Sperm cell processing and preservation systems
EP2306174B1 (fr) 2003-03-28 2016-05-11 Inguran, LLC Buse de cytométrie en flux pour orienter des particles et procédé correspondant

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4818103A (en) * 1981-05-15 1989-04-04 Ratcom Flow cytometry
US4606636A (en) * 1983-10-25 1986-08-19 Universite De Saint-Etienne Optical apparatus for identifying the individual multiparametric properties of particles or bodies in a continuous flow
NL8601000A (nl) * 1986-04-21 1987-11-16 Jan Greve T H Twente Afdeling Het gebruik van gepolariseerd licht in stromingscytometrie.
US5057413A (en) * 1988-06-13 1991-10-15 Becton, Dickinson And Company Method for discriminating between intact and damaged cells in a sample
US4954715A (en) * 1989-06-26 1990-09-04 Zoeld Tibor Method and apparatus for an optimized multiparameter flow-through particle and cell analyzer
ATE304170T1 (de) * 1994-08-01 2005-09-15 Abbott Lab Verfahren und vorrichtung zur durchführung automatischer analysen
US5631165A (en) * 1994-08-01 1997-05-20 Abbott Laboratories Method for performing automated hematology and cytometry analysis
JP3324050B2 (ja) * 1994-10-31 2002-09-17 日本光電工業株式会社 白血球分類用試薬および白血球分類方法
US5650847A (en) * 1995-06-14 1997-07-22 Erkki Soini Method and device for determination of parameters of individual microparticles
JP3504029B2 (ja) * 1995-07-04 2004-03-08 シスメックス株式会社 粒子分析装置
DE59710824D1 (de) * 1996-05-03 2003-11-13 Ciba Sc Holding Ag Optische Speichermedien mit hoher Kapazität, die Xanthenfarbstoffe enthalten
DE19700648A1 (de) * 1997-01-10 1998-07-23 Basf Ag Verfahren und Vorrichtung zur Bestimmung der Größenverteilung von verschiedenartigen Partikeln in einer Probe
JP3642658B2 (ja) * 1997-06-30 2005-04-27 シスメックス株式会社 尿中有形成分分析装置および分析方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0049387A3 *

Also Published As

Publication number Publication date
AU768616B2 (en) 2003-12-18
JP2002537557A (ja) 2002-11-05
WO2000049387A2 (fr) 2000-08-24
CA2329031A1 (fr) 2000-08-24
AU768616C (en) 2004-12-16
AU3597600A (en) 2000-09-04
CA2329031C (fr) 2003-09-23
WO2000049387A3 (fr) 2001-02-15
WO2000049387A9 (fr) 2001-09-27

Similar Documents

Publication Publication Date Title
AU2002327820B2 (en) High numerical aperture flow cytometer and method of using same
AU2002327820A1 (en) High numerical aperture flow cytometer and method of using same
US6320656B1 (en) High numerical aperture flow cytometer and method of using same
US7390662B2 (en) Method and apparatus for performing platelet measurement
EP0311655B1 (fr) Dispositif d'analyse differentielle multi-elements faisant appel a des techniques de dispersion de lumiere
US5492833A (en) Reticulocyte analyzing method and apparatus utilizing light scatter techniques
EP0442025B1 (fr) Appareil optique d'analyse de particules avec deux espèces de sources lumineuses
JP2815435B2 (ja) 粒子解析装置及び血球カウンタ
US20030048433A1 (en) Cytometer signal processing system and method
JPH05322885A (ja) 尿中の細胞分析装置
JPH0129576Y2 (fr)
AU768616C (en) High numerical aperture flow cytometer and method of using same
JP3504029B2 (ja) 粒子分析装置
JP3504030B2 (ja) 粒子判定基準の決定方法およびその装置並びにその判定基準を用いた粒子分析装置
Gray et al. A new method for cell volume measurement based on volume exclusion of a fluorescent dye
Burger et al. Acousto‐optic laser‐scanning cytometer
JPS6193932A (ja) 粒子分析装置

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20001024

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20070116